Your browser doesn't support javascript.
loading
Immediate impact of the COVID-19 pandemic on CTSA TL1 and KL2 training and career development.
McCormack, Wayne T; Bredella, Miriam A; Ingbar, David H; Jackson, Rebecca D; Meagher, Emma A; Morris, Cynthia D; Nagel, Joan D; Pusek, Susan; Rubio, Doris M; Sandberg, Kathryn; Schnaper, H William; Tsevat, Joel; Umans, Jason G; McIntosh, Scott.
Afiliação
  • McCormack WT; Clinical & Translational Science Institute, Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Bredella MA; Harvard Catalyst, The Harvard Clinical and Translational Science Center, Harvard Medical School, Boston, MA, USA.
  • Ingbar DH; Clinical and Translational Science Institute Research Education, Career Development, and Training Core, Department of Medicine, University of Minnesota School of Medicine, Minneapolis, MN, USA.
  • Jackson RD; The Center for Clinical and Translational Science, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
  • Meagher EA; Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Morris CD; Oregon Clinical and Translational Research Institute, Oregon Health & Science University, Portland, OR, USA.
  • Nagel JD; National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.
  • Pusek S; NC TraCS Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Rubio DM; Institute for Clinical Research Education, Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, PA, USA.
  • Sandberg K; Georgetown-Howard Universities Center for Clinical and Translational Science, Washington, DC, USA.
  • Schnaper HW; Northwestern University Clinical and Translational Sciences (NUCATS) Institute, Northwestern University, Chicago, IL, USA.
  • Tsevat J; Institute for the Integration of Medicine and Science, Center for Research to Advance Community Health, Department of Medicine, Long School of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Umans JG; Georgetown-Howard Universities Center for Clinical and Translational Science, Washington, DC, USA.
  • McIntosh S; Center for Leading Innovation and Collaboration, Department of Public Health Sciences, University of Rochester Medical Center, Rochester, NY, USA.
J Clin Transl Sci ; 4(6): 556-561, 2020 Jun 29.
Article em En | MEDLINE | ID: mdl-33942017
Clinical and Translational Science Award (CTSA) TL1 trainees and KL2 scholars were surveyed to determine the immediate impact of the COVID-19 pandemic on training and career development. The most negative impact was lack of access to research facilities, clinics, and human subjects, plus for KL2 scholars lack of access to team members and need for homeschooling. TL1 trainees reported having more time to think and write. Common strategies to maintain research productivity involved time management, virtual connections with colleagues, and shifting to research activities not requiring laboratory/clinic settings. Strategies for mitigating the impact of the COVID-19 pandemic on training and career development are described.
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article